Skip to content

duoABLE for People With Stroke and Their Caregivers

duoABLE for People With Stroke and Their Caregivers (Feasibility)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05964400
Enrollment
16
Registered
2023-07-27
Start date
2023-09-01
Completion date
2024-08-24
Last updated
2024-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke, Stroke Hemorrhagic, Stroke Ischemic, Stroke Sequelae

Keywords

lifestyle, physical activity, duoABLE, ABLE, rehabilitation, rehab, occupational therapy, physical therapy, stroke

Brief summary

The goal of this intervention study is to test whether a behavioral program that involves people with stroke and their caregivers is acceptable, safe, and can promote physically active lifestyles using enjoyable activities. Participant duos (person with stroke and their caregiver) will be asked to complete assessments at 2 timepoints, wear an activity tracker, participate in 12 sessions with an occupational therapist, and complete an interview.

Interventions

BEHAVIORALduoABLE

Stroke participant-caregiver duos (dyads) will meet with an occupational therapist 12 times (2x/week for 6 weeks, approximately 30 minutes/session) to apply activity monitoring, activity scheduling, collaborative problem solving, self-assessment, and social interdependence to self-selected activities that aim to increase both dyad members' physical activity levels

Sponsors

American Occupational Therapy Foundation
CollaboratorOTHER
University of Minnesota
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

(Stroke Participants): * Stroke diagnosed more than 6 months ago * Are 18 years of age or older * Report ≥6 hours of sedentary behavior on a typical day OR report engagement in ≤90 minutes of moderate-to-vigorous physical activity in the past week * Reside in a community-based setting * Are mobile within their home, with or without an assistive device and without physical assistance * Are able to identify an eligible caregiver who will engage in assessments and intervention. Inclusion Criteria (Caregiver Participants): * Are 18 years of age or older * Report ≥6 hours of sedentary behavior on a typical day OR report engagement in ≤90 minutes of moderate-to-vigorous physical activity in the past week * Reside in a community-based setting * Are mobile within their home, with or without an assistive device and without physical assistance

Exclusion criteria

(Stroke Participants): * Severe aphasia * Are currently receiving chemotherapy or radiation treatments for cancer * Have a medical diagnosis of neurodegenerative disorder (i.e., dementia, Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis, glioblastoma) * Received inpatient treatment for substance use disorder or psychiatric condition within the past 12 months * Have a history of skin sensitivity related to adhesives * Are pregnant or expecting to become pregnant in the next 2 months * Reside in an institutional setting * Are currently incarcerated

Design outcomes

Primary

MeasureTime frameDescription
Participant satisfactionScore at week 8Measured using the Client Satisfaction Questionnaire-8 (CSQ-8)

Secondary

MeasureTime frameDescription
Change in daily step countBaseline to 8 weeksCount of steps per day, measured using the activPAL micro4 (mean daily step count determined by 7-day wear protocol) at baseline and week 8.
Change in sedentary minutes per dayBaseline to 8 weeksMinutes of sedentary time per day, measured using the activPAL micro4 (mean minutes per day determined by 7-day wear protocol) at baseline and week 8.
Change in activity restrictionsBaseline to 8 weeksProportion of activities retained assessed at baseline and 8-weeks by the Activity Card Sort 3
Change in Health-related quality of lifeBaseline to 8 weeksChange in score on the EuroQoL-5 Dimensions-5 Levels (EQ-5D-5L) measured at baseline and week 8
Adverse event countCount of adverse events at week 8Total count of adverse events over the course of the study based on an adverse events questionnaire completed at 8 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026